How Viking Therapeutics Stock Could 30x
Viking Therapeutics (NASDAQ: VKTX) has been one of the few bright spots in the healthcare sector this year. The biotech's shares have stormed higher by almost 300% year to date on the back of its midstage weight-loss candidate, VK2735.
The lowdown is that VK2735 could be a top three weight-loss medication in terms of sales, according to some analyst estimates. That's a potentially incredible opportunity for risk-tolerant investors.
Image Source: Getty Images.
Source Fool.com
Viking Therapeutics Inc Aktie
48,26 €
-1,65 %
Viking Therapeutics Inc erfreut sich mäßiger Beliebtheit, mit mehr Buy- als Sell-Einschätzungen.
Die Community prognostiziert für Viking Therapeutics Inc ein Kursziel von 100 €, was den aktuellen Kurs von 48.26 € weit übertrifft.
